Mingyu Zhang
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Mapping the genetic-transcriptional landscape of thyroid irAEs in sintilimab therapy: toward biomarker-guided immunotoxicity prediction.
Journal: Frontiers in immunology
Published: July 23, 2025
Mechanism exploration of Salvia miltiorrhiza Bunge against trastuzumab induced cardiotoxicity via multi-omics.
Journal: Journal of ethnopharmacology
Published: April 18, 2025
Novel progressive deep learning algorithm for uncovering multiple single nucleotide polymorphism interactions to predict paclitaxel clearance in patients with nonsmall cell lung cancer.
Journal: Cancer innovation
Published: September 26, 2023
Improving Chuanxiong Rhizoma quality standards using an effect-constituent index based bioassay.
Journal: Journal of pharmaceutical and biomedical analysis
Published: March 13, 2023
The roles of ubiquitin-proteasome system and regulator of G protein signaling 4 in behavioral sensitization induced by a single morphine exposure.
Journal: Brain and behavior
Published: November 22, 2022
Comparing the cost-effectiveness of sintilimab + pemetrexed plus platinum and pemetrexed plus platinum alone as a first-line therapy for Chinese patients with nonsquamous non-small cell lung cancer.
Journal: Translational cancer research
Published: August 28, 2022
Metabolomics Combined with Network Pharmacology-Based Strategy to Reveal the Underlying Mechanism of Zhenhuang Submicron Emulsion in Treating Oropharyngeal Mucositis Complications of Radiation Therapy for Head and Neck Cancer.
Journal: Drug design, development and therapy
Published: June 09, 2022
Cost-effectiveness of pembrolizumab versus docetaxel as second-line treatment of non-small cell lung cancer in China.
Journal: Annals of translational medicine
Published: July 26, 2021
A Comprehensive Analysis of Metabolomics and Transcriptomics Reveals Novel Biomarkers and Mechanistic Insights on Lorlatinib Crosses the Blood-Brain Barrier.
Journal: Frontiers in pharmacology
Published: June 09, 2021
An Integrative Metabolomic and Network Pharmacology Study Revealing the Regulating Properties of Xihuang Pill That Improves Anlotinib Effects in Lung Cancer.
Journal: Frontiers in oncology
Published: April 19, 2021
Effect of Single-Dose and Short-Term Administration of Si Jun Zi Tang on the Pharmacokinetics of Gefitinib in Rats.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: January 06, 2021
Spectrum-effect relationship between UPLC fingerprints and anti-lung cancer effect of Panax ginseng.
Spectrum-effect relationship between UPLC fingerprints and anti-lung cancer effect of Panax ginseng.
Journal: Phytochemical analysis : PCA
Published: May 11, 2020
Last Updated: 09/26/2026